Literature DB >> 8201941

The structure-activity relationships of flavonoids as inhibitors of cytochrome P-450 enzymes in rat liver microsomes and the mutagenicity of 2-amino-3-methyl-imidazo[4,5-f]quinoline.

H Lee1, H W Wang, H Y Su, N J Hao.   

Abstract

The antimutagenicity of 19 naturally occurring flavonoids and their derivatives including flavones, flavonols, flavanones, isoflavones and flavanols were determined using Salmonella typhimurium TA98 against 2-amino-3-methylimidazo[4,5-f] quinoline (IQ) in the presence of Aroclor 1254-induced rat hepatic S9. In general, a relationship between the chemical structure of flavonoids and their antimutagenicity was found for compounds containing one or more of the following features: (i) C4 keto group, (ii) aglycone, (iii) double bond at positions C2 and C3, (iv) phenyl group at position C2, and (v) three hydroxy substituents at positions C4', C5 and C7. The inhibitory effects of flavonoids on activities of 7-ethoxycoumarin deethylase (ECD) and 7-ethoxyresorufin deethylase (ESD) of Aroclor 1254-induced hepatic microsomes were also examined. In addition, we studied the effects of flavonoids on the metabolism of IQ by Aroclor 1254-induced microsomes using high-performance liquid chromatography. The antimutagenicity correlated with the inhibition of cytochrome P-450IA1-linked ESD and P-450IA2-linked ECD activity in hepatic microsomes, and with an inhibition of N-hydroxy-IQ formation from IQ metabolism by hepatic microsomes. These results indicated that flavones or flavonols that contain C5, C7 and C4' hydroxyl groups are potent inhibitors of P-450 enzyme activities induced by Aroclor 1254 (P-450IA1 and P-450IA2), and may potentially be useful as chemopreventive agents against heterocyclic amine-induced mutagenesis or carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8201941     DOI: 10.1093/mutage/9.2.101

Source DB:  PubMed          Journal:  Mutagenesis        ISSN: 0267-8357            Impact factor:   3.000


  6 in total

Review 1.  Dietary factors and epigenetic regulation for prostate cancer prevention.

Authors:  Emily Ho; Laura M Beaver; David E Williams; Roderick H Dashwood
Journal:  Adv Nutr       Date:  2011-11-03       Impact factor: 8.701

2.  Differential effects of whole soy extract and soy isoflavones on apoptosis in prostate cancer cells.

Authors:  Anna Hsu; Tammy M Bray; William G Helferich; Daniel R Doerge; Emily Ho
Journal:  Exp Biol Med (Maywood)       Date:  2010-01

3.  Anti-inflammatory activity of soy and tea in prostate cancer prevention.

Authors:  Anna Hsu; Tammy M Bray; Emily Ho
Journal:  Exp Biol Med (Maywood)       Date:  2010-06

4.  In vitro inhibition of midazolam and quinidine metabolism by flavonoids.

Authors:  H R Ha; J Chen; P M Leuenberger; A U Freiburghaus; F Follath
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

5.  Heterocyclic amines: occurrence and prevention in cooked food.

Authors:  S Robbana-Barnat; M Rabache; E Rialland; J Fradin
Journal:  Environ Health Perspect       Date:  1996-03       Impact factor: 9.031

6.  Effect of protein source and resistance training on body composition and sex hormones.

Authors:  Douglas Kalman; Samantha Feldman; Michele Martinez; Diane R Krieger; Mark J Tallon
Journal:  J Int Soc Sports Nutr       Date:  2007-07-23       Impact factor: 5.150

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.